Sharing Life Sciences Innovations

Join our 20.000 subscribers and receive the monthly newsletter for free!

Upcoming events

6th Biopharm Day Seminar

Lindner Hotel, Lange Kievitstraat 125, 2018 Antwerpen, Belgium
Thu 04 Oct 2018
09:30

It is with great pleasure that SGS invites you to join this R&D seminar. It will address the new early phase clinical trials paradigm. This ‘new look’ seminar has evolved in its format to incl…

Read more

Business Developers Program for Life Sciences - Course

Amsterdam, The Netherlands
Tue 25 Sep 2018 - Wed 26 Sep 2018
25 Sep 08:30 - 26 Sep 17:30

On 25 & 26 September 2018 the Business Developers Program (BDP) Course will take place at the EY office in Amsterdam. This BDP Course specifically aims at junior to mid-level BD professionals who …

Read more

Spice up your knowledge of single-cell technology and come meet the experts

New York Genome Center, 101 6th Avenue, New York City, USA
Fri 28 Sep 2018
08:30

Organized by VIB (Flemish Interuniversity Institute for Biotechnology) and the Government of Flanders, Belgium and supported by JLABS and NY Genome Center: Program 8:30am :  Registration - W…

Read more

Forever young: the science of aging well

Forever young: the science of aging well

“Is aging a disease?” For a long time, the answer to this question seemed obvious: aging is a natural thing that happens to all of us. It is an inevitable side-effect of growing older. However…

Read more

Argenx raised over $300 million in their US public offering

18 September 2018 - Read the press release here. Argenx is a Belgian clinical-stage biotechnology company, developing differentiated antibody-based therapies for the treatment of severe autoim…

Read more

V-Bio Ventures participates in 22.5 million euros series B financing round of Horama

Ghent (Belgium), September 18th, 2018 - The Belgian life sciences venture fund V-Bio Ventures (www.v-bio.ventures) today announces that it joins the “Series B” financing round of Horama (www.horam…

Read more

Argenx announces launch of proposed public offering in the United States

Hot on the tail of Galapagos' successful public offering, Gent-based biotech Argenx is following suit! The biotech company, which is developing antibody-based therapies for cancer and autoimmune d…

Read more

Saving lives through fundamental research: James Allison wins Dr. Paul Janssen Award 2018

Saving lives through fundamental research: James Allison wins Dr. Paul Janssen Award 2018

Dr. James Allison has dedicated his career to improving our fundamental understanding of how the adaptive immune system works. Much of what you will find on T cells in today’s immunology textbooks…

Read more

Can weeds be programmed to exterminate themselves?

Can weeds be programmed to exterminate themselves?

Walking through a forest on a breezy September day, the very air seems to crackle with colour and life. The irony is, of course, that as you walk through trees with golden, crimson leaves, the vas…

Read more

How CRISPR/Cas9 is improving drug development using zebrafish

How CRISPR/Cas9 is improving drug development using zebrafish

CRISPR/Cas9 came to the attention of scientists everywhere over five years ago. Ever since it hit the main stage, the gene editing technique has stayed in the spotlight, and for good reason. CRISP…

Read more

Uncovering the secrets of inflammasomes

Uncovering the secrets of inflammasomes

Mohamed (Mo) Lamkanfi made the jump from academia to industry a mere eight months ago, to pursue a career with the Janssen Pharmaceutical Companies of Johnson & Johnson, as Head, Innate Immunity, …

Read more

The world's smallest diamonds

The world's smallest diamonds

Researchers at Hasselt University have just synthesised the world’s smallest diamonds. The gems, based on a 26-atom carbon core, will be useful in a whole range of industrial and medical applicati…

Read more

New beta cell antigens discovered in Type 1 diabetes

New beta cell antigens discovered in Type 1 diabetes

A study published just last week has unveiled several new antigens implicated in Type 1 diabetes. In an ongoing project, researchers are working to understand the immune system failures that cause…

Read more

Biotechs and subsidies - a fraught relationship

Biotechs and subsidies - a fraught relationship

The ambition of any CEO heading a biotech start-up is to develop a new product and to reach patients quickly. However, drug development comes with long development timelines, making Biotech a capi…

Read more

Acquisitions of Biotech companies: a good or a bad thing?

Acquisitions of Biotech companies: a good or a bad thing?

When on the 8th January 2018 the news travelled that Novo Nordisk made a €2.6bn bid for Belgium’s Ablynx, only to be leapfrogged a few weeks later by the € 3.9bn Sanofi bid, we immediately picture…

Read more

Join our 20.000 subscribers and receive the monthly newsletter for free!

Upcoming events

6th Biopharm Day Seminar

Lindner Hotel, Lange Kievitstraat 125, 2018 Antwerpen, Belgium
Thu 04 Oct 2018
09:30

It is with great pleasure that SGS invites you to join this R&D seminar. It will address the new early phase clinical trials paradigm. This ‘new look’ seminar has evolved in its format to incl…

Read more

Business Developers Program for Life Sciences - Course

Amsterdam, The Netherlands
Tue 25 Sep 2018 - Wed 26 Sep 2018
25 Sep 08:30 - 26 Sep 17:30

On 25 & 26 September 2018 the Business Developers Program (BDP) Course will take place at the EY office in Amsterdam. This BDP Course specifically aims at junior to mid-level BD professionals who …

Read more

Spice up your knowledge of single-cell technology and come meet the experts

New York Genome Center, 101 6th Avenue, New York City, USA
Fri 28 Sep 2018
08:30

Organized by VIB (Flemish Interuniversity Institute for Biotechnology) and the Government of Flanders, Belgium and supported by JLABS and NY Genome Center: Program 8:30am :  Registration - W…

Read more

Sign up to our Mailing List to receive updates
of our latest News, Events & Magazines

GSK Flanders.bio Turnstone XpandInnovation V-Bio Ventures UGent KU Leuven Itera Life Science Biowin Janssen

ABOUT BIOVOX - Sharing Life Sciences Innovations

BioVox showcases interesting life sciences breakthroughs for and from Belgian innovators. Through our partnership with BioCentury we share relevant worldwide innovations and business updates while our local journalists focus on regional highlights. 

Interested to get involved? Get in touch! We are looking for content, writers and partners! Blogs are available for research institutes, companies and freelance experts.

You want to reach out to the biotechnology and life sciences community, targetting selected audiences? Discover our sponsor and publication opportunities as well as tailored packages!

Contact BioVox via news@biovox.be or by completing the contact form.